MINNEAPOLIS, Dec. 6, 2017 /PRNewswire/ -- Cogentix
Medical, Inc. (NASDAQ: CGNT), announced today that Palmetto
GBA, LLC, a Medicare Administrative Contractor serving
approximately 4.5 million lives, has extended its coverage policy
for Percutaneous Tibial Nerve Stimulation (PTNS) to allow patients
with overactive bladder symptoms to receive ongoing maintenance
treatments for up to three years. Patients with Medicare coverage
in North Carolina, South Carolina, most of Virginia and West
Virginia can continue to receive the benefits of PTNS
therapy delivered by Cogentix Medical's Urgent PC
Neuromodulation System for their overactive bladder (OAB) symptoms
for an additional year.
"On behalf of the many overactive bladder patients who can
benefit from Urgent PC's therapeutic benefits, we applaud
Palmetto's decision to extend its coverage policy for PTNS
maintenance treatments from two to three years," said Darin Hammers, President and CEO of Cogentix
Medical. "We believe this update underscores the value of
Urgent PC as a long-term treatment option for an indication that
has substantial unmet clinical need."
A low-risk, office-based therapy for overactive bladder and
associated symptoms of urinary urgency, urinary frequency and urge
incontinence, Urgent PC is a recommended therapy within the
American Urological Association/Society of Urodynamics, Female
Pelvic Medicine & Urogenital Reconstruction (AUA/SUFU)
OAB diagnosis and treatment guidelines. Dr. Scott MacDiarmid, a urologist specializing in
treating patients with OAB based in Greensboro, NC, stated, "Our office and, more
importantly, our patients, were very excited regarding the recent
decision by Palmetto to extend their coverage for PTNS. PTNS is a
very important therapy for overactive bladder and it plays an
integral role in helping us deliver excellence to our
patients."
Urgent PC is a recommended third-line treatment in the AUA/SUFU
guidelines for patients who have not met their treatment goals with
behavioral therapies or bladder medications. Up to 80% of patients
have symptom improvement during the initial 12 Urgent PC treatments
and the majority of these patients are able to maintain the results
long-term with monthly treatments.
For more detailed information about the extended coverage for
PTNS, please visit the CMS website at:
https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=33443.
About Overactive Bladder
It is estimated that 42 million people in the United States alone have OAB, of which
approximately 38 million remain untreated or undertreated. OAB
occurs when bladder muscles become overly sensitive or overactive,
which typically results from damage to the nervous system or to the
nerves and muscles associated with bladder contractility. Symptoms
of OAB include urinary urgency, urinary frequency or urge
incontinence.
About Cogentix Medical
Cogentix Medical, Inc., is a global medical device company. We
design, develop, manufacture and market products for flexible
endoscopy with our unique PrimeSight™ product lines featuring a
streamlined visualization system and proprietary sterile disposable
microbial barrier providing users with efficient and cost-effective
endoscope turnover while enhancing patient safety. We also
commercialize the Urgent® PC Neuromodulation System, an
FDA-cleared device that delivers Percutaneous Tibial Nerve
Stimulation (PTNS) for the office-based treatment of overactive
bladder (OAB). OAB is a chronic condition that affects
approximately 42 million U.S. adults. The symptoms include urinary
urgency, frequency and urge incontinence. We also offer
Macroplastique®, an injectable urethral bulking agent for the
treatment of adult female stress urinary incontinence primarily due
to intrinsic sphincter deficiency. We are is headquartered in
Minnetonka, Minnesota, with
additional operations in New York,
Massachusetts, The Netherlands and the United Kingdom, For more information on
Cogentix Medical and our products, please visit us at
www.cogentixmedical.com.
For Further
Information:
Cogentix Medical,
Inc.
Brett Reynolds, SVP
and CFO
952-426-6152
Lazar
Partners
David
Carey
212-867-1768
|
View original
content:http://www.prnewswire.com/news-releases/cogentix-medical-announces-palmetto-gba-extends-medicare-coverage-on-urgent-pc-300567209.html
SOURCE Cogentix Medical, Inc.